Business Wire

SHINE Medical Technologies Closes $150-million Series C-5 Financing to Advance Nuclear Fusion-Based Technologies

JANESVILLE, Wis.--(BUSINESS WIRE)--SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. Koch Disruptive Technologies (KDT) led the round, which also ...
The Business Journals

SHINE Technologies awarded eight-figure grant from Dutch government

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The funds are in support of ...
St. Louis American

SHINE Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility

Blue Earth Therapeutics will leverage SHINE’s non-carrier added lutetium-177 chloride, Ilumira, in a new treatment for prostate cancer undergoing clinical trials JANESVILLE, Wis., June 6, 2024 ...

Wave Shine Tech Advances Wireless Infrastructure with Tile-Based Reconfigurable Intelligent Surfaces (RIS)

Power-independent modular RIS for eliminating wireless blind spots in 6G and beyond. SAN FRANCISCO, CA, UNITED STATES, ...
The Business Journals

Million-dollar grant energizes Janesville tech company

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Shine Technologies has made a ...
AOL

SHINE Medical Technologies lands major funding from a Koch Industries company

Jun. 30—JANESVILLE — SHINE Medical Technologies announced Tuesday it has received a major, $150 million boost as it moves toward completion and commercialization of its Janesville medical nuclear ...
FOX8 Cleveland

SHINE Technologies, LLC Announces Submission of FDA Drug Master File for Non-Carrier-Added Lutetium-177

JANESVILLE, Wis., April 8, 2024 /PRNewswire/ -- SHINE Technologies, LLC (SHINE), a pioneer in next-generation fusion-based technology, becomes North America's largest producer of non-carrier added ...